Analysis of polymorphisms and selective pressures on ama1 gene in Plasmodium knowlesi isolates from Sabah, Malaysia

Chuen Yang Chua1, Ping Chin Lee, Tiek Ying Lau

  • 1Biotechnology Research Institute, Universiti Malaysia Sabah, 88400 Kota Kinabalu, Sabah, Malaysia. sophialau@ums.edu.my.

Journal of Genetics
|September 27, 2017
PubMed

Insights

Polymorphisms in Plasmodium knowlesi's apical membrane antigen-1 (AMA-1) pose challenges for malaria vaccine development. However, domain II of AMA-1 shows low diversity and purifying selection, suggesting its potential as a vaccine target.

Area of Science:

  • Malariology
  • Molecular Biology
  • Vaccine Development

Background:

  • Apical membrane antigen-1 (AMA-1) is crucial for Plasmodium merozoite invasion of erythrocytes.
  • Polymorphisms in AMA-1 present significant hurdles for developing effective malaria vaccines.

Purpose of the Study:

  • To characterize the ama1 gene in Plasmodium knowlesi isolates from Sabah.
  • To assess the potential of PkAMA-1 domains for malaria vaccine development.

Main Methods:

  • DNA extraction from blood samples from Sabah.
  • Nested PCR amplification and bidirectional sequencing of the Pkama1 gene.
  • Analysis of nucleotide polymorphisms, haplotype identification, and selection pressure (dN/dS ratios, Fu and Li's D and F tests).

Main Results:

  • Most nucleotide polymorphisms in Pkama1 were synonymous and located in domain I.
  • Fourteen haplotypes were identified, with K5 being the most common.
  • Purifying and negative selection were prevalent in Pkama1, particularly in domain II, with low overall nucleotide diversity.

Conclusions:

  • Domain II of PkAMA-1 exhibits low nucleotide diversity and evidence of purifying selection.
  • These characteristics suggest that domain II of PkAMA-1 is a promising target for malaria vaccine development.